In vivo and in vitro olefin cyclopropanation catalyzed by heme enzymes

US10208322B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10208322-B2
Application numberUS-201615278561-A
CountryUS
Kind codeB2
Filing dateSep 28, 2016
Priority dateOct 9, 2012
Publication dateFeb 19, 2019
Grant dateFeb 19, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides methods for catalyzing the conversion of an olefin to any compound containing one or more cyclopropane functional groups using heme enzymes. In certain aspects, the present invention provides a method for producing a cyclopropanation product comprising providing an olefinic substrate, a diazo reagent, and a heme enzyme; and admixing the components in a reaction for a time sufficient to produce a cyclopropanation product. In other aspects, the present invention provides heme enzymes including variants and fragments thereof that are capable of carrying out in vivo and in vitro olefin cyclopropanation reactions. Expression vectors and host cells expressing the heme enzymes are also provided by the present invention.

First claim

Opening claim text (preview).

What is claimed is: 1. A reaction mixture for producing a cyclopropanation product, the reaction mixture comprising an olefinic substrate, a diazo reagent, and a heme enzyme variant; wherein the heme enzyme variant can cyclopropanate an olefinic substrate. 2. The reaction mixture of claim 1 , wherein the cyclopropanation product is a compound according to Formula I: wherein: R 1 is independently selected from the group consisting of H, optionally substituted C 1-18 alkyl, optionally substituted C 6-10 aryl, optionally substituted 6- to 10-membered heteroaryl, halo, cyano, C(O)OR 1a , C(O)N(R 7 ) 2 , C(O)R 8 , C(O)C(O)OR 8 , and Si(R 8 ) 3 ; R 2 is independently selected from the group consisting of H, optionally substituted C 1-18 alkyl, optionally substituted C 6-10 aryl, optionally substituted 6- to 10-membered heteroaryl, halo, cyano, C(O)OR 2a , C(O)N(R 7 ) 2 , C(O)R 8 , C(O)C(O)OR 8 , and Si(R 8 ) 3 ; wherein R 1a and R 2a are independently selected from the group consisting of H, optionally substituted C 1-18 alkyl and -L-R c , wherein each L is selected from the group consisting of a bond, —C(R L ) 2 -, and —NR L —C(R L ) 2 -, each R L is independently selected from the group consisting of H, C 1-6 alkyl, halo, —CN, and -SO 2 , and each R C is selected from the group consisting of optionally substituted C 6-10 aryl, optionally substituted 6- to 10-membered heteroraryl, and optionally substituted 6- to 10-membered heterocyclyl; and R 3 , R 4 , R 5 , and R 6 are independently selected from the group consisting of H, C 1-18 alkyl, C 2-18 alkenyl, C 2-18 alkynyl, optionally substituted C 6-10 aryl, optionally substituted C 1 -C 6 alkoxy, halo, hydroxy, cyano, C(O)N(R 7 ) 2 , NR 7 C(O)R 8 , C(O)R 8 , C(O)OR 8 , and N(R 9 ) 2 , wherein each R 7 and R 8 is independently selected from the group consisting of H, optionally substituted C 1-12 alkyl, optionally substituted C 2-12 alkenyl, and optionally substituted C 6-10 aryl; and each R 9 is independently selected from the group consisting of H, optionally substituted C 6-10 aryl, and optionally substituted 6- to 10-membered heteroaryl, or two R 9 moieties, together with the nitrogen atom to which they are attached, can form 6- to 18-membered heterocyclyl; or R 3 forms an optionally substituted 3- to 18-membered ring with R 4 ; or R 5 forms an optionally substituted 3- to 18-membered ring with R 6 ; or R 3 or R 4 forms a double bond with R 5 or R 6 ; or R 3 or R 4 forms an optionally substituted 5- to 6-membered ring with R 5 or R 6 . 3. The reaction mixture of claim 1 , wherein the olefinic substrate is selected from the group consisting of an alkene, a cycloalkene, and an arylalkene. 4. The reaction mixture of claim 3 , wherein the olefinic substrate has the formula: wherein R 3 is selected from the group consisting of H, optionally substituted C 1 -C 6 alkyl, optionally substituted C 1 -C 6 alkoxy, C(O)N(R 7 ) 2 , C(O)OR 8 , N(R 9 ) 2 , halo, hydroxy, and cyano; R 5 and R 6 are independently selected from the group consisting of H, optionally substituted C 1-6 alkyl, and halo; R 10 is selected from the group consisting of optionally substituted C 1 -C 6 alkyl, optionally substituted C 1 -C 6 alkoxy, halo, and haloalkyl; and the subscript r is an integer from 0 to 2. 5. The reaction mixture of claim 1 , wherein the diazo reagent has a structure according to the formula: wherein: R 1 is independently selected from the group consisting of H, optionally substituted C 1-18 alkyl, optionally substituted C 6-10 aryl, optionally substituted 6- to 10-membered heteroaryl, halo, cyano, C(O)OR 1a , C(O)N(R 7 ) 2 , C(O)R 8 , C(O)C(O)OR 8 , and Si(R 8 ) 3 ; and R 2 is independently selected from the group consisting of H, optionally substituted C 1-18 alkyl, optionally substituted C 6-10 aryl, optionally substituted 6- to 10-membered heteroaryl, halo, cyano, C(O)OR 2 a, C(O)N(R 7 ) 2 , C(O)R 8 , C(O)C(O)OR 8 , and Si(R 8 ) 3 ; wherein R 1a and R 2a are independently selected from the group consisting of H, optionally substituted C 1-18 alkyl and -L-R C , wherein each L is selected from the group consisting of a bond, —C(R L ) 2 -, and —NR L —C(R L ) 2 -, each R L is independently selected from the group consisting of H, C 1-6 alkyl, halo, —CN, and -SO 2 , and each R C is selected from the group consisting of optionally substituted C 6-10 aryl, optionally substituted 6- to 10-membered heteroraryl, and optionally substituted 6- to 10-membered heterocyclyl; and each R 7 and R 8 is independently selected from the group consisting of H, optionally substituted C 1-12 alkyl, optionally substituted C 2-12 alkenyl, and optionally substituted C 6-10 aryl. 6. The reaction mixture of claim 1 , wherein the heme enzyme is a cyctochrome P450 enzyme or a variant thereof. 7. The reaction mixture of claim 1 , wherein the heme enzyme is a globin or a variant thereof.

Assignees

Inventors

Classifications

  • using catalysts, e.g. selective catalysts · CPC title

  • NADPH-cytochrome P450 reductase (1.6.2.4) · CPC title

  • C12P13/02Primary

    Amides, e.g. chloramphenicol {or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes (peptides C12P21/00 or C07K)} · CPC title

  • Oxidoreductases (1.) · CPC title

  • C12P7/62Primary

    Carboxylic acid esters · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10208322B2 cover?
The present invention provides methods for catalyzing the conversion of an olefin to any compound containing one or more cyclopropane functional groups using heme enzymes. In certain aspects, the present invention provides a method for producing a cyclopropanation product comprising providing an olefinic substrate, a diazo reagent, and a heme enzyme; and admixing the components in a reaction fo…
Who is the assignee on this patent?
California Inst Of Techn
What technology area does this patent fall under?
Primary CPC classification C12P13/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).